HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT05553639 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Decision by the company to terminate the H-300-001 study early for non-safety related reasons.

Conditions

Interventions

Sponsor

Hookipa Biotech GmbH